45
Participants
Start Date
December 8, 2024
Primary Completion Date
August 20, 2038
Study Completion Date
October 15, 2038
Assessments
Safety and efficacy assessments
Tianjin Institute of Hematology, Tianjin
Nanfang Hospital, Southern Medical University, Guangzhou
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou
Shenzhen Children 's Hospital, Shenzhen
Xiangya Hospital of Central South University, Changsha
No. 923 Hospital of Joint Support Force of Chinese People 's Liberation Army Hospital, Nanning
The First Affiliated Hospital of GUANGXI MEDICAL UNIVERSITY, Guangxi
Lead Sponsor
First Affiliated Hospital of Guangxi Medical University
OTHER
Xiangya Hospital of Central South University
OTHER
Chinese Academy of Medical Sciences
OTHER
Nanfang Hospital, Southern Medical University
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
OTHER
Shenzhen Children 's Hospital
UNKNOWN
Bioray Laboratories
INDUSTRY